Africa strikes deal with Pfiz­er for Covid-19 an­tivi­ral — re­port

As the FDA looks to make Pfiz­er’s Covid-19 an­tivi­ral more ac­ces­si­ble in the US, Africa’s CDC has re­port­ed­ly struck an agree­ment with the phar­ma gi­ant to in­crease sup­plies across the con­ti­nent.

The health agency has reached a mem­o­ran­dum of un­der­stand­ing with Pfiz­er which will al­low African coun­tries to ac­cess Paxlovid at cost, ac­cord­ing to a Reuters re­port. 

The news comes just a few months af­ter re­searchers with the Drugs for Ne­glect­ed Dis­eases Ini­tia­tive re­port­ed that they were de­nied ac­cess to Paxlovid for use in a large study in 10 African coun­tries in a va­ri­ety of set­tings and in some com­bi­na­tions with oth­er ther­a­pies. Pfiz­er al­leged­ly told the re­searchers that it al­ready had plans to con­duct sim­i­lar tri­als, ac­cord­ing to a Na­ture re­port. 

Endpoints News

Unlock this article instantly by becoming a free subscriber.

You’ll get access to free articles each month, plus you can customize what newsletters get delivered to your inbox each week, including breaking news.